EEA1

EEA1, or early endosome antigen 1, is a membrane bound Rab5 effector protein specific to the early endosome and plays an important role in membrane trafficking. Early endosomes fuse with endocytic vesicles to redistribute compounds to other cellular destinations. EEA1 contains a C-terminal FYVE domain that binds to phosphatidylinositol-3-phosphate, which targets it to early endosomes [1, 2].

EEA1, or Early Endosome Antigen 1 is a Rab5 effector essential for early endocytic membrane fusion. The EEA1 antibody is used in membrane trafficking and chaperone studies, and as an endosome marker. We at Novus Biologicals have a comprehensive antibody catalog of EEA1 products.

EEA1, or Early Endosome Antigen 1, is a phospholipid-binding protein essential for endosomal membrane trafficking and fusion, and is a useful endosomal marker. We at Novus Biologicals have an extensive EEA1 antibody catalog, with antibodies that have been cited in many publications.